Abstract: A system and method to treat neural communication impairment is provided. The neural communication impairment is present in a neural pathway, which can be a cortico-neuromuscular pathway, an intra-brain neural pathway, or in a sensory-cortico pathway. A synchronized external stimulation is applied to a first point in proximity to a first neural component at one end of the neural pathway and to a second point in proximity to a second neural component at the other end of the neural pathway. Two induced neural handshake signals contemporaneously arrive at a neural communication impairment point in the neural pathway, triggering and stimulating a rehabilitation process by which the neural connection is permanently improved. The synchronized applied electrical signals applied to the first and second points may have an opposite polarity in dipolar neural stimulation, or may have identical polarity and waveform in in-phase neural stimulation.
Type:
Grant
Filed:
January 17, 2014
Date of Patent:
November 21, 2017
Assignee:
The Research Foundation of the City University of New York
Abstract: This disclosure relates to graphene derivatives, as well as related devices including graphene derivatives and methods of using graphene derivatives.
Type:
Grant
Filed:
May 16, 2016
Date of Patent:
November 21, 2017
Assignee:
Research Foundation of The City University of New York
Inventors:
Michele Vittadello, Kamil Woronowicz, Manish Chhowalla, Paul G. Falkowski, John W. Harrold, Jr.
Abstract: A method for delegating a computational burden from a computationally limited party to a computationally superior party is disclosed. Computations that can be delegated include inversion and exponentiation modulo any number m. This can be then used for sending encrypted messages by a computationally limited party in a standard cryptographic framework, such as RSA. Security of delegating computation is not based on any computational hardness assumptions, but instead on the presence of numerous decoys of the actual secrets.
Type:
Grant
Filed:
July 9, 2015
Date of Patent:
November 21, 2017
Assignee:
Research Foundation of the City University of New York
Inventors:
Delaram Kahrobaei, Bren Cavallo, Vladimir Shpilrain
Abstract: Industrial waste derived adsorbents were obtained by pyrolysis of sewage sludge, metal sludge, waste oil sludge and tobacco waste in some combination. The materials were used as media to remove hydrogen sulfide at room temperature in the presence of moisture. The initial and exhausted adsorbents after the breakthrough tests were characterized using sorption of nitrogen, thermal analysis, XRD, ICP, and surface pH measurements. Mixing tobacco and sludges result in a strong synergy enhancing the catalytic properties of adsorbents. During pyrolysis new mineral phases are formed as a result of solid state reaction between the components of the sludges. High temperature of pyrolysis is beneficial for the adsorbents due to the enhanced activation of carbonaceous phase and chemical stabilization of inorganic phase. Samples obtained at low temperature are sensitive to water, which deactivates their catalytic centers.
Type:
Grant
Filed:
April 27, 2016
Date of Patent:
November 7, 2017
Assignee:
RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK
Abstract: Modulation of target effector organs in vertebrate beings using direct current stimulation for stimulation of spinal cord at regions of autonomic innervation, using direct current for peripheral nerve stimulation, by modulating central autonomic outflow and combinations thereof.
Type:
Application
Filed:
July 17, 2017
Publication date:
November 2, 2017
Applicant:
The Research Foundation of the City University of New York
Abstract: The invention provides compositions with low toxicity and high bioavailability for treating cancer or for inhibiting the development of cancer.
Type:
Grant
Filed:
May 24, 2013
Date of Patent:
October 31, 2017
Assignee:
The Research Foundation of the City University of New York
Abstract: A method for treating a biological cell is disclosed. The method administers a mixture of a chemotherapeutic drug and a co-drug that facilitates delivery of the chemotherapeutic drug to the nucleus of the cell. Examples of co-drugs include cationic polymers, cationic lipids and cationic proteins. Cationic polymers include a polyethyleneimine (PEI), polylysine, a polybetaaminoester (PBAE), an ?-polylysine (EPL) including ?-poly-L-lysine (e-PLL), a polyarginine peptide, chitosan, a polyamidoamine dendrimer (PAMAM). Cationic lipids include 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP). Cationic proteins include protamine.
Type:
Grant
Filed:
May 4, 2016
Date of Patent:
October 24, 2017
Assignee:
RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK
Abstract: Effective systems and methods for improving neural communication impairment of a vertebrate being and affecting motor activity of a peripheral body part including a first signal providing component configured to provide pulsed peripheral stimulation signals at the peripheral body part, a second signal providing component configured to provide a pulsed motor cortex stimulation signal to a motor cortex area, a substantially DC signal providing component configured to provide direct current spinal stimulation signal at a neural spinal junction and a controller component configured to control timing of the pulsed peripheral stimulation signals and the pulsed motor cortex stimulation signal.
Type:
Grant
Filed:
June 30, 2016
Date of Patent:
October 17, 2017
Assignee:
THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK
Abstract: A polymer with antibacterial activity is provided. The polymer has multiple groups of cationic amines, each group spaced from the polymer backbone by alkylene spacers of different lengths. The resulting polymer maintains significant antibacterial activity while having reduced hemolytic activity relative to a homopolymer that uses hexylene spacers.
Type:
Grant
Filed:
October 9, 2014
Date of Patent:
September 12, 2017
Assignee:
Research Foundation of the City University of New York
Abstract: A device for producing electrolyte flow in a flow-assisted battery comprises a flow assisted battery, a powering device located on a dry side of a battery housing, and an impeller assembly located on a wet side of the battery housing. The flow assisted battery comprises a battery housing, an anode, a cathode and an electrolyte solution, where the anode, the cathode and the electrolyte solution are disposed within the battery housing. The impeller assembly comprises: a shaft, an impeller, and one or more interior magnets, and the powering device and the impeller assembly are magnetically coupled through the battery housing.
Type:
Grant
Filed:
November 13, 2013
Date of Patent:
August 8, 2017
Assignee:
Research Foundation of the City University of New York
Abstract: Modulation of target effector organs in vertebrate beings using direct current stimulation for stimulation of spinal cord at regions of autonomic innervation, using direct current for peripheral nerve stimulation, by modulating central autonomic outflow and combinations thereof.
Type:
Grant
Filed:
June 22, 2016
Date of Patent:
July 18, 2017
Assignee:
The Research Foundation of the City University of New York
Abstract: Modulation of target effector organs in vertebrate beings using direct current stimulation for stimulation of spinal cord at regions of autonomic innervation, using direct current for peripheral nerve stimulation, by modulating central autonomic outflow and combinations thereof.
Type:
Grant
Filed:
June 22, 2016
Date of Patent:
July 18, 2017
Assignee:
The Research Foundation of the City University of New York
Abstract: A method for producing a light oil fraction from plant-based and/or animal-based fats, oils or greases is disclosed. The method comprises introducing a feedstock including free fatty acids into a processing system. The system is heated at a controlled rate to a specified temperature, both of which are selected to produce a light oil fraction with a reduced fatty acid content. The system is permitted to reflux for a predetermined time, during which more of the light oil fraction is produced. The light oil fraction is separated from the remainder of the feedstock and contains less than 10% free fatty acids.
Type:
Grant
Filed:
November 8, 2013
Date of Patent:
July 11, 2017
Assignees:
Research Foundation of the City University of New York, University of Connecticut
Inventors:
Lawrence M. Pratt, Richard Steven Parnas
Abstract: A quantum well infrared photodetector (QWIP) and method of making is disclosed. The QWIP includes a plurality of epi-layers formed into multiple periods of quantum wells, each of the quantum wells being separated by a barrier, the quantum wells and barriers being formed of II-VI semiconductor materials. A multiple wavelength QWIP is also disclosed and includes a plurality of QWIPs stacked onto a single epitaxial structure, in which the different QWIPs are designed to respond at different wavelengths. A dual wavelength QWIP is also disclosed and includes two QWIPs stacked onto a single epitaxial structure, in which one QWIP is designed to respond at 10 ?m and the other at 3-5 ?m wavelengths.
Type:
Grant
Filed:
February 20, 2014
Date of Patent:
July 4, 2017
Assignees:
THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK, THE TRUSTEES OF PRINCETON UNIVERSITY
Inventors:
Arvind Ravikumar, Claire Gmachl, Aidong Shen, Maria Tamargo
Abstract: This disclosure relates to novel compounds containing an H2S releasing moiety and a nitric oxide (NO) releasing moiety covalently linked with a core (e.g., a salicylic acid moiety) and the use of such compounds in treating inflammatory diseases, including cancers. Therapeutic potency of these compounds is significantly higher than NSAIDs containing a H2S-releasing moiety alone (HS-NSAIDs) and NSAID containing a NO-releasing moiety alone (NO-NSAIDs). The compounds, in addition, exhibit reduced side effect, e.g., reduced stomach ulcers, upon administration.
Type:
Grant
Filed:
August 15, 2012
Date of Patent:
June 27, 2017
Assignee:
Research Foundation of The City University of New York
Abstract: A drive unit for driving a robot along an inclined surface is disclosed. An endless tread engages a pair of wheels to define a planar bottom surface of the endless tread. A vacuum motor pulls air through holes in the endless tread when the holes are aligned with a vacuum opening.
Type:
Grant
Filed:
March 13, 2014
Date of Patent:
June 27, 2017
Assignees:
Research Foundation of The City University of New York, InnovBot, LLC
Abstract: Methods are provided for modifying and screening for carotenoid biosynthesis in a plant. The methods are useful for enhancing plant adaptation to climate change and food security, providing increased carotenoid content to a plant, improving stress resistance to climate changes in a plant, and for selecting plants having improved stress resistance to climate changes.
Type:
Grant
Filed:
August 15, 2013
Date of Patent:
June 13, 2017
Assignee:
Research Foundation of The City University of New York
Abstract: Xanthochymol and garcinol, isoprenylated benzophenones purified from Garcinia xanthochymus fruits, showed multiple activities against fungal biofilms. Both compounds effectively prevented emergence of fungal germ tubes and were also cytostatic, with MICs of 1 to 3 ?M. The compounds therefore inhibited development of hyphae and subsequent biofilm maturation. Xanthochymol treatment of developing and mature biofilms induced cell death. In early biofilm development, killing had the characteristics of apoptosis. These activities resulted in failure of biofilm maturation and hyphal death in mature biofilms. In mature biofilms, xanthochymol and garcinol caused the death of biofilm hyphae, with 50% effective concentrations (EC50s) of 30 to 50 ?M. Additionally, xanthochymol-mediated killing was complementary with fluconazole against mature biofilms, reducing the fluconazole EC50 from greater than 1,024 ?g per ml to 13 ?g per ml.
Type:
Grant
Filed:
April 25, 2016
Date of Patent:
May 16, 2017
Assignee:
Research Foundation of City University of New York
Inventors:
Desmond N. Jackson, Edward N. Kennelly, Peter Lipke
Abstract: In the present invention, different strategies are used to improve the bioavailability of triterpene glycosides and triterpenes including, for example, (a) a covalent approach involving modification with polyethylene glycol and (b) a formulation approach involving non-covalent encapsulation in antibody targeted pol(DL-lactic acid) nanoparticles.
Type:
Grant
Filed:
January 17, 2014
Date of Patent:
May 9, 2017
Assignee:
RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK